Difficulty: Medium
Average Score: 76%
Practice
Which class of oral glucose-lowering agents is most commonly used for people with type 2 diabetes because it reduces hepatic glucose production and enhances tissue uptake of glucose?
Correct answer
B
Rationale
The correct answer is B) Meglitinide. Meglitinides are a class of oral glucose-lowering agents commonly used for people with type 2 diabetes because they work by stimulating insulin secretion from pancreatic beta cells. This action helps to reduce hepatic glucose production and enhance the uptake of glucose by tissues, thereby lowering blood sugar levels. Meglitinides are particularly useful for individuals who have irregular meal schedules or who struggle with hypoglycemia.
A) Insulin is not the most commonly used oral glucose-lowering agent for type 2 diabetes. Insulin is typically administered via injection and is reserved for cases where oral medications are insufficient in controlling blood sugar levels.
C) Biguanides, like metformin, work by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues. While a commonly prescribed medication for type 2 diabetes, it does not directly stimulate insulin secretion like meglitinides.
D) Sulfonylureas work by stimulating insulin secretion from pancreatic beta cells similar to meglitinides. However, sulfonylureas have a longer duration of action and are associated with a higher risk of hypoglycemia compared to meglitinides.
In an educational context, understanding the mechanisms of action of different classes of oral glucose-lowering agents is crucial for healthcare professionals managing patients with type 2 diabetes. By knowing how each medication works, healthcare providers can make informed decisions to tailor treatment plans to individual patient needs, considering factors such as meal schedules, risk of hypoglycemia, and overall efficacy in controlling blood sugar levels.
A) Insulin is not the most commonly used oral glucose-lowering agent for type 2 diabetes. Insulin is typically administered via injection and is reserved for cases where oral medications are insufficient in controlling blood sugar levels.
C) Biguanides, like metformin, work by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues. While a commonly prescribed medication for type 2 diabetes, it does not directly stimulate insulin secretion like meglitinides.
D) Sulfonylureas work by stimulating insulin secretion from pancreatic beta cells similar to meglitinides. However, sulfonylureas have a longer duration of action and are associated with a higher risk of hypoglycemia compared to meglitinides.
In an educational context, understanding the mechanisms of action of different classes of oral glucose-lowering agents is crucial for healthcare professionals managing patients with type 2 diabetes. By knowing how each medication works, healthcare providers can make informed decisions to tailor treatment plans to individual patient needs, considering factors such as meal schedules, risk of hypoglycemia, and overall efficacy in controlling blood sugar levels.